California Bureau of Cannabis Control Grants Expanded License

OAKLAND, CA

,

May 13, 2021

/PRNewswire/ –


Harborside Inc.


(“Harborside” or the “Company”) (CSE: HBOR),(OTCQX: HBORF) a

California

-focused, vertically integrated cannabis enterprise, today announced that it has received approval from the California Bureau of Cannabis Control to commence adult-use retail sales at its existing San Leandro Wellness Solutions (“SLWS”) dispensary. As previously announced, Harborside received a six-month lease extension at its existing SLWS location, permitting the Company sufficient time to finalize terms of a lease and subsequent build out of a new retail dispensary location in

San Leandro

. The new location is expected to provide greater customer visibility and lower overhead expenses.

“We are thrilled to have received approval to commence adult-use sales in

San Leandro

,” said

Peter Bilodeau

, Interim CEO of Harborside. “This has been a long process and we are excited to expand our potential customer base to provide them with the best-in-class service and unbeatable product selection that Harborside is known for. With our upcoming move to a more efficient location in

San Leandro

, I look forward to deepening our relationship with the local community and continuing to serve our patients and customers.

Upon completion, Harborside’s new

San Leandro

location is expected to enable the Company to better serve its customers while also reducing its rent and thus increasing profitability. As a result of the planned move, Harborside expects to be able to generate substantially more revenue and be more profitable by reducing its operating costs more than

$2 million

over the 10-year lease term.

For the latest news, activities, and media coverage, please visit the Harborside corporate website at

www.investharborside.com

or connect with us on


LinkedIn


and


Twitter


.

About Harborside:


Harborside Inc. is one of the oldest and most respected cannabis retailers in

California

, operating three of the major dispensaries in the

San Francisco Bay Area

, a dispensary in the

Palm Springs

area outfitted with

Southern California’s

only cannabis drive-thru window, a dispensary in

Oregon

and a cultivation/production facility in

Salinas, California

. Harborside has played an instrumental role in making cannabis safe and accessible to a broad and diverse community of

California

consumers. In 2006, Harborside was awarded one of the first six medical cannabis licenses granted in

the United States

and today holds cannabis licenses for retail, distribution, cultivation, nursery and manufacturing. Harborside is currently a publicly listed company on the Canadian Securities Exchange (“CSE”) trading under the ticker symbol “HBOR”. Additional information regarding Harborside is available under Harborside’s SEDAR profile at


www.sedar.com


.

Cautionary Note Regarding Forward-Looking Information

This news release contains “forward-looking information” and “forward-looking statements” (collectively, “forward- looking statements”) within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates, and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements include, among other things, securing new retail space, completion of the buildout, regulatory approval, expected increased profitability, expected revenue projections, and expected reductions in operating costs.

These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance, or achievements of the Company to materially differ from any future results, performance, or achievements expressed or implied by such forward-looking statements. Such factors, among other things, include: implications of the COVID-19 pandemic on the Company’s operations; fluctuations in general macroeconomic conditions; fluctuations in securities markets; expectations regarding the size of the cannabis markets where the Company operates; changing consumer habits; the ability of the Company to successfully achieve its business objectives; plans for expansion; political, social and environmental uncertainties; inability to obtain adequate insurance to cover risks and hazards; employee relations and the presence of laws and regulations that may impose restrictions on cultivation, production, distribution, and sale of cannabis and cannabis-related products in the markets where the Company operates. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.

The Company, through several of its subsidiaries, is indirectly involved in the manufacture, possession, use, sale, and distribution of cannabis in the recreational and medicinal cannabis marketplace in

the United States

. Local state laws where the Company operates permit such activities however, these activities are currently illegal under

United States

federal law. Additional information regarding this and other risks and uncertainties relating to the Company’s business are contained under the heading “Risk Factors” in the Listing Statement dated

May 30, 2019

, and in the Company’s management’s discussion and analysis for the period ended

September 30, 2020

, filed under the Company’s profile on SEDAR at

www.sedar.com

.

The CSE has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

View original content to download multimedia:

http://www.prnewswire.com/news-releases/harborside-receives-approval-to-commence-adult-use-sales-at-san-leandro-dispensary-301290830.html

SOURCE Harborside Inc.